United States · FDA National Drug Code directory
Clindamycin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8685_f22b8915-c4dd-4a51-ab2e-2b77a73526da
- Product NDC
- 68788-8685
- Form
- CAPSULE
- Composition / generic term
- Clindamycin Hydrochloride
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240601
- Source listing expiry
- 20271231
Source-listed ingredients
- CLINDAMYCIN HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 CAPSULE in 1 BOTTLE (68788-8685-1) · 68788-8685-1
- 20 CAPSULE in 1 BOTTLE (68788-8685-2) · 68788-8685-2
- 30 CAPSULE in 1 BOTTLE (68788-8685-3) · 68788-8685-3
- 40 CAPSULE in 1 BOTTLE (68788-8685-4) · 68788-8685-4
- 56 CAPSULE in 1 BOTTLE (68788-8685-5) · 68788-8685-5
- 60 CAPSULE in 1 BOTTLE (68788-8685-6) · 68788-8685-6
- 21 CAPSULE in 1 BOTTLE (68788-8685-8) · 68788-8685-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →